Pharma-Bio Serv (PBSV) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PBSV Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Pharma-Bio Serv.
Quarterly Report, GAAP in USD millions
ITEM
(Jul 31 2026)
(Apr 30 2026) (Jan 31 2026) (Oct 31 2025) (Jul 31 2025)
Assets
Marketable Securities7.06
Cash & Short-term Investments7.00
Accounts receivable2.42
Other Current Assets1.52
Total loans net0.24
Total Current Assets11.24
Equipment/Property/Plant Net0.08
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent0.12
Total Assets11.44
Liabilities
Accounts Payable0.93
Taxes Payable0.07
Total Current Liabilities0.99
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities0.99
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value0.00
Additional Paid In Capital Common Stock1.71
Retained Earnings / Accumulated Deficit9.07
Accumulated Other Comprehensive Income0.25
Other Equity0.25
Common Stockholder's Equity10.44
Total Stockholder's Equity10.44
Liabilities & Stockholder's Equity11.44
4 historic quarters locked

Sign in to unlock the full Pharma-Bio Serv balance sheet history.

About Pharma Bio Serv Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260731)
  • Filed with the SEC: September 14, 2026
  • Source: pbsv_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001654954-26-008346

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.